Trump's New Health Data Tracking System Raises Privacy Concerns
President Donald Trump has announced a plan for a new private health tracking system that will make it easier for patients to access their health records and monitor their wellness across health care systems and technologies. The system, however, is raising a host of privacy questions.
The collaboration between the federal government and Big Tech would allow patients to more seamlessly track and share their medical records or data among doctors, hospital systems and health apps, the administration and participating companies say.
Details of the system were announced Wednesday during a White House event dubbed "Making Health Technology Great Again."
The system would be maintained by the federal government through the Centers for Medicare and Medicaid Services, pulling health data kept by Big Tech companies like Amazon, Google and Apple as well as major health companies like hospital system Cleveland Clinic and insurer UnitedHealth Group. Patients will need to opt in to have their medical records and data shared, which CMS says will be kept secure.
Once a patient is in the system, their information could be shared across apps or health systems that have joined the initiative. So, for example, the Apple Health app on your iPhone that tracks your daily step count or your sleep could access lab results from your doctor's office. Putting that information together, the Trump administration says, will offer a fuller picture of your health.
Apps and AI technology could also help people make better choices at the grocery store or identify patterns in their day-to-day life that might be affecting their health, said US Health and Human Services Secretary Robert F Kennedy Jr during Wednesday's White House event.
"Now if you have your medical records, you can get personalised advice," Kennedy said.
Currently, there's no unified database where a person's health data and medical records are kept. Each health system stores, shares and releases patients' records in different ways, with some even still faxing records to doctors working in other offices or hospitals. Some health networks have their own apps or websites that allow patients to look up their records online.
The US Department of Health and Human Services says that 60 companies have signed on to work with the system and that they have pledged to "deliver results to the American people in the first quarter of 2026."
The Trump administration, however, made a similar proposal back in 2018 that never fully came to fruition.
Patient advocates and ethicists say many may worry about how their health information - something Americans have long carefully guarded - could be used in ways that they don't want or expect.
"There are enormous ethical and legal concerns," said Lawrence Gostin, a Georgetown University law professor who specializes in public health. "Patients across America should be very worried that their medical records are going to be used in ways that harm them and their families."
Also, digital privacy advocates say they are skeptical that patients will be able to count on their data being stored securely.
"This scheme is an open door for the further use and monetization of sensitive and personal health information," said Jeffrey Chester at the Center for Digital Democracy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
16 minutes ago
- Time of India
Trump pressures 17 pharma CEOs to cut US drug prices
Donald Trump has asked major pharmaceutical companies to lower US drug prices. He wants them to match the prices paid in other countries. Trump sent letters to companies like Eli Lilly and Pfizer. He wants them to offer the best prices to Medicaid patients. Trump has given the companies time until September 29 to respond. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S. prescription drug prices to match those paid overseas, the White House said on signed a sweeping executive order in May demanding drugmakers cut U.S. medicine prices to match those abroad, saying that if companies did not comply, the government could use rulemaking to bring prices down or pursue other measures, such as importing cheaper medicines from sent the letters to the chief executives of Eli Lilly , Sanofi, Regeneron, Merck & Co , Johnson & Johnson, and AstraZeneca , among others, the White House said."Most proposals my Administration has received to 'resolve' this critical issue promised more of the same; shifting blame and requesting policy changes that would result in billions of dollars in handouts to industry," Trump wrote in the letters, copies of which were posted on his Truth Social of Pfizer , Eli Lilly and Gilead Sciences closed down about 2% each, while the NYSE Arca Pharmaceutical Index fell 3% on called on drugmakers to provide so-called most-favored-nation prices to every patient enrolled in the government Medicaid health program for low-income people, and to guarantee such pricing for new policy is aimed at cutting U.S. prescription drug prices to the lowest possible price paid by members of the Organisation for Economic Co-operation and Development, which includes most of the world's largest also said companies must return excess overseas revenue from raising prices in other countries to offset lower prices in the U.S. to American patients and taxpayers through an agreement with the is requiring drugmakers to stipulate they would not offer other developed nations better prices than what they offer the United States, and said his administration would provide ways to cut out middlemen and sell directly to patients, provided they do so at most-favored-nation gave companies until September 29 to respond with binding commitments to those terms."If you refuse to step up, we will deploy every tool in our arsenal to protect Americans from abusive drug pricing practices," he lobbyists and drug pricing experts said it seemed unlikely that the pharmaceutical companies would comply with Trump's demand to lower U.S. prices."I might expect them to try to determine if any of their current products might be made available via direct sales (one of the requests) at a lower price than currently available in the U.S.," said Stacie Dusetzina, professor of health policy at Nashville's Vanderbilt analyst Trung Huynh said Trump's letters were a repeat of earlier demands and played down any likely industry impact, calling it "just another shot in the dark."Trump has already pushed for voluntary changes and some companies have pledged to build new U.S. manufacturing plants.U.S. patients pay by far the most for prescription medicines, often nearly three times more than in other developed nations. The country also invests heavily in pharmaceutical research and development. Drugmakers have said drastic price cuts would stifle companies including Pfizer, Novartis , AbbVie, and German Merck KGaA's U.S. division, EMD Serono, said they were open to working with the Trump is working closely with the Trump Administration and Congress to improve access and affordability for American patients, said spokeswoman Amy Rose. "Our discussions have been productive," she said.
Time of India
20 minutes ago
- Time of India
Ultra-processed foods like bread, soda, and noodles may raise lung cancer risk: Study
A US study published in Thorax found that adults consuming the most ultra-processed foods (UPFs) - such as bread, soda, instant noodles, ice cream, breakfast cereals, and lunch meats- are 41% more likely to develop lung cancer than those eating the least. This association persisted even after adjusting for smoking status, general diet quality, and other factors, highlighting a significant potential link between widespread dietary patterns and cancer. With UPFs accounting for more than half of daily calories in typical American and UK diets, the findings emphasise the urgent need to reevaluate the fertility of food environments, reduce UPF intake, and promote whole-food-based nutrition. What are ultra-processed foods and how might they promote lung cancer Ultra‑processed foods are industrially formulated products made from ingredients rarely used in home cooking. They typically include additives like emulsifiers, preservatives, artificial colours/flavours, high levels of sugar, salt, and unhealthy fats, and are ready-to-eat or reheated. Common examples include soft drinks, processed snacks, instant noodles, frozen meals, lunch meats, sugary cereals, ice cream, margarine, and shop-bought sauces and pizzas. They are identified using the NOVA classification system, which organises foods based on their processing level. Several mechanisms may explain why high UPF intake is associated with lung cancer risk : Poor nutritional quality: UPFs are often high in sugar, saturated fats, salt, and low in fiber, vitamins, and micronutrients. This promotes obesity and metabolic disturbances linked to cancer. Additives and contaminants: Chemicals used in processing and packaging—like emulsifiers, preservatives, artificial colours, acrolein (also present in tobacco smoke), bisphenol A, and phthalates- may promote inflammation, hormonal disruption, DNA damage, and gut microbiota imbalance. Overconsumption and obesogenic effect: Highly palatable, calorie-dense UPFs drive overconsumption and weight gain, which is itself a strong risk factor for various cancers. Tips for reducing ultra-processed food consumption If you're concerned about the potential health risks associated with ultra-processed foods, there are several steps you can take to reduce your consumption. Here are a few tips: Read labels carefully: Check the ingredient list and nutrition label to identify ultra-processed foods. Cook from scratch: Preparing meals from whole ingredients can help you avoid ultra-processed foods. Choose whole foods: Focus on whole, unprocessed foods like fruits, vegetables, whole grains, and lean proteins. Limit packaged snacks: Opt for healthier snack options like nuts, seeds, and fruits. Also read | Why you should start drinking water from copper bottle; know its health benefits
Time of India
an hour ago
- Time of India
The surprising link between hearing loss and dementia
If you think hearing loss is 'just' an old age problem, or only means you'll ask people to repeat themselves, read on: not keeping your ears healthy might actually put your brain at risk, too. Multiple studies have shown that folks with hearing loss have a higher risk of developing dementia compared to those with normal hearing. To get specific: Older Americans with moderate or severe hearing loss were found to have a 61% higher prevalence of dementia compared to people with normal hearing. Untreated hearing loss is now considered the single largest modifiable risk factor for dementia, according to the influential 2020 Lancet Commission on Dementia . And—it's not just about Alzheimer's. Hearing loss is associated with all-cause dementia, not just one specific type. How does hearing loss affect the brain? Alright, so why does not hearing well mess with your memory and thinking? Here's what the science from various research studies suggest: Cognitive load: With hearing loss, your brain has to work a lot harder just to understand words. It ends up burning mental energy on listening, so less is available for memory, learning, and thinking. Over time, this 'cognitive overload' might wear down the brain's resources. Brain changes: When the brain isn't getting regular input from the ears, the areas responsible for processing sound can shrink or weaken , sort of like 'use it or lose it.' Social isolation: People with hearing loss often retreat from conversations and social activities. Loneliness and less mental stimulation create a perfect storm for dementia risk. Biological effects: There's some research showing other brain changes, like increased levels of proteins linked to Alzheimer's, in people with age-related hearing loss. What about hearing aids? Do they help? Here's the exciting part! Several major studies, including a nationwide trial funded by the NIH and led by Johns Hopkins, are showing that treating hearing loss may help lower dementia risk: Hearing aid users with hearing loss had a 32% lower prevalence of dementia compared to non-users in a large national sample. One big randomized trial (ACHIEVE) is tracking almost 1,000 older adults with hearing loss to see if those using hearing aids score better on memory and thinking over several years. Early results are promising and suggest that hearing aids could slow cognitive decline, especially in people with high dementia risk. Should you worry about your ears? If you're thinking 'I'm too young for this'—rethink that! The most important research shows that midlife hearing loss (not just in your 70s or 80s) is key. Catching and treating hearing loss early could make a huge difference for your brain down the road. Tips for protecting both ears and mind Get your hearing tested regularly, especially from age 50 and up. Don't ignore mild hearing loss. Even small changes matter over time. Consider hearing aids or assistive devices if recommended, they're not just for 'old folks,' and using them might literally protect your brain. Stay socially active even if you have hearing challenges, don't let hearing struggles push you into isolation. Keep your body and brain healthy: Treat other risk factors like high blood pressure, diabetes, and get plenty of exercise and mental stimulation. Bottom line? Taking care of your hearing is actually a big part of taking care of your mind. If you or a loved one is struggling to hear, don't brush it off—it's not just about missing words, but about keeping your memory, mood, and mind sharp for years to come.
